Survival in breast cancer is familial

Breast Cancer Research and Treatment

Volumn 110, Issue 1, 2008, Pages 177-182

  Hemminki, Kari ^a,b   Ji, Jianguang ^b   Försti, Asta ^a,b   Sundquist, Jan ^b   Lenner, Per ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Familial breast cancer; Heredity; Heritability of survival; Metastasis; Prognosis

Indexed keywords

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DAUGHTER; FAMILY HISTORY; FEMALE; FOLLOW UP; HAZARD RATIO; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; FEMALE; HUMANS; PROBABILITY; PROPORTIONAL HAZARDS MODELS;

EID: 44849094464     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9692-7     Document Type: Article

References (34)

1. Talback M, Stenbeck M, Rosen M, Barlow L, Glimelius B (2003) Cancer survival in Sweden 1960-1998-developments across four decades. Acta Oncol 42:637-659
2. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC et al (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407-1427
3. Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F (2006) Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer 119:2417-2422
4. Jatoi I, Miller A (2003) Why is breast-cancer mortality declining? Lancet Oncol 4:251-254
5. Shen Y, Yang Y, Inoue L, Munsell M, Miller A, Berry D (2005) Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 97:1195-1203
6. Chappuis P, Rosenblatt J, Foulkes W (1999) The influence of familial and hereditary factors on the prognosis of breast cancer. Ann Oncol 10:1163-1170
7. Russo A, Herd-Smith A, Gestri D, Bianchi S, Vezzosi V, Rosselli Del Turco M, Cardona G (2002) Does family history influence survival in breast cancer cases? Int J Cancer 99:427-430
8. Verkooijen HM, Chappuis PO, Rapiti E, Vlastos G, Fioretta G, Sarp S, Sappino AP, Schubert H, Bouchardy C (2006) Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer 94:231-238
9. Figueiredo JC, Ennis M, Knight JA, McLaughlin JR, Hood N, O'Malley F, Andrulis IL, Goodwin PJ (2006) Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Res Treat
10. The Breast Cancer Association Consortium (2006) Commonly studies single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 98:1382-1396
11. Brekelmans CT, Seynaeve C, Menke-Pluymers M, Bruggenwirth HT, Tilanus-Linthorst MM, Bartels CC, Kriege M, van Geel AN, Crepin CM, Blom JC et al (2006) Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 17:391-400
12. Bonadona V, Dussart-Moser S, Voirin N, Sinilnikova OM, Mignotte H, Mathevet P, Bremond A, Treilleux I, Martin A, Romestaing P et al (2007) Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review. Breast Cancer Res Treat 101:233-245
13. Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjord JE (2006) Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. J Natl Cancer Inst 98:116-122
14. Hahn WC, Weinberg RA (2002) Rules for making human tumor cells. N Engl J Med 347:1593-1603
15. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10:789-799
16. Furuta E, Bandyopadhyay S, Iiizumi M, Mohinta S, Zhan R, Watabe K (2006) The role of tumor metastasis suppressors in cancers of breast and prostate. Front Biosci 11:2845-2860
17. Weigelt B, Peterse JL, van 't Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591-602
18. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J et al (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24:3726-3734
19. Jansen MP, Sieuwerts AM, Look MP, Ritstier K, Meijer-van Gelder ME, van Staveren IL, Klijn JG, Foekens JA, Berns EM (2007) HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study. J Clin Oncol 25:662-668
20. Nguyen DX, Massague J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8:341-352
21. Hemminki K, Li X, Plna K, Granström C, Vaittinen P (2001) The nation-wide Swedish family-cancer database: updated structure and familial rates. Acta Oncol 40:772-777
22. Hemminki K, Granström C, Sundquist J, Lorenzo Bermejo J (2006) The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence. Heredit Cancer in Clin Pract 4:186-192
23. Center for Epidemiology: Cancer Incidence in Sweden 2002. In: Stockholm The National Board of Health and Welfare; 2004: http://www.sos.se
24. Hemminki K, Rawal R, Lorenzo Bermejo J (2004) Mammographic screening is dramatically changing age-incidence data for breast cancer. J Clin Oncol 22:4652-4653
25. Hemminki K, Lorenzo Bermejo J (2005) Effects of screening for breast cancer on its age-incidence relationships and familial risk. Int J Cancer 117:145-149
26. Jonsson H, Johansson R, Lenner P (2005) Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 117:842-847
27. Olsson S, Andersson I, Karlberg I, Bjurstam N, Frodis E, Hakansson S (2000) Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen 7:14-18
28. Moller B, Weedon-Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M, Haldorsen T (2005) The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev 14:117-128
29. Loktionov A (2004) Common gene polymorphisms, cancer progression and prognosis. Cancer Lett 208:1-33
30. Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W et al (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647-3653
31. Forsti A, Jin Q, Altieri A, Johansson R, Wagner K, Enquist K, Grzybowska E, Pamula J, Pekala W, Hallmans G, Lenner P, Hemminki K (2007) Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. Breast Cancer Res Treat 101:83-93
32. Lei H, Hemminki K, Altieri A, Johansson R, Enquist K, Hallmans G, Lenner P, Forsti A (2007) Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Res Treat 103:61-69
33. Lei H, Hemminki K, Johansson R, Altieri A, Enquist K, Henriksson R, Lenner P, Forsti A (2007) PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer. Breast Cancer Res Treat (in press)
34. Lorenzo Bermejo J, Hemminki K (2005) Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst 97:1575-1579